Concepedia

Author

Zvezdana Hlebanja

Institute of Oncology Ljubljana

Also Known As

Hlebanja Zvezdana, Hlebanja, Zvezdana, Horvat, Samo, Z Hlebanja, Zvezdana Hlebanja

19

Publications

173

Citations

4

H-Index

12

Concepts

All Affiliations

Institute of Oncology Ljubljana
ZH

About

Zvezdana Hlebanja is an author at Institute of Oncology Ljubljana specializing in liver, liver physiology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

57

2

Hepatology

1

1

57

3

Pathology

1

1

57

4

Cancer Research

1

1

57

5

Cirrhosis

1

1

57

Zvezdana Hlebanja

×

4

Publications

168

Citations

4

H-Index

YearCitations

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

Erik Škof, Martina Reberšek, Zvezdana Hlebanja,

BMC Cancer

2009

69

Spontaneous regression of hepatocellular carcinoma.

Slobodan Marković, Ferlan‐Marolt, Zvezdana Hlebanja

PubMed

1996

57

Randomized Prospective Phase II Study to Compare the Combination Chemotherapy Regimen Epirubicin, Cisplatin, and 5-Fluorouracil With Epirubicin, Cisplatin, and Capecitabine in Patients With Advanced or Metastatic Gastric Cancer

Janja Ocvirk, Martina Reberšek, Erik Škof,

American Journal of Clinical Oncology

2011

24

Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis

Martina Reberšek, Marko Boc, Petra Cerkovnik,

Radiology and Oncology

2011

18

Page 1